CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,611,345 | -19.1% | 35,500 | 0.0% | 0.56% | -27.5% |
Q2 2023 | $1,992,970 | +24.1% | 35,500 | 0.0% | 0.78% | +21.9% |
Q1 2023 | $1,605,666 | +11.3% | 35,500 | 0.0% | 0.64% | +29.0% |
Q4 2022 | $1,443,075 | -37.8% | 35,500 | 0.0% | 0.49% | -49.0% |
Q3 2022 | $2,320,000 | +7.6% | 35,500 | 0.0% | 0.97% | +13.5% |
Q2 2022 | $2,157,000 | -3.2% | 35,500 | 0.0% | 0.85% | +34.4% |
Q1 2022 | $2,228,000 | – | 35,500 | – | 0.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |